Search

everythinglearnresearchcommunity

for

Search:↓

A woman with systemic sclerosis developed a unique scarring hair loss combining features of systemic sclerosis and frontal fibrosing alopecia.

New treatments and diagnostic methods for various animal skin conditions showed promising results.

Methotrexate caused a rare skin rash in a rheumatoid arthritis patient, which resolved after stopping the drug.

Raltitrexed conjugates are less potent than the free drug but more effective at high concentrations.

MTX and GC combinations are the most effective for early rheumatoid arthritis.

Ruxolitinib can cause a delayed skin reaction on the nose.

Ixekizumab helps improve life quality, physical ability, and work performance in patients with psoriatic arthritis who haven't used biologic drugs before.

Ritlecitinib effectively treats severe Alopecia Areata by reducing harmful immune activity in the skin.

Topical ruxolitinib quickly improves non-segmental vitiligo.

ARQ-234, a protein designed to treat atopic dermatitis, shows increased effectiveness in early testing.

Tislelizumab can cause cutaneous lupus erythematosus.

Ruxolitinib reduced inflammation and improved symptoms in APECED patients but may cause anemia and weight gain.

A patient's grey hair regained color during treatment with adalimumab.

Infliximab improved skin and bowel symptoms in Crohn's disease but caused side effects and the disease returned after stopping treatment.

Ritlecitinib may be more effective for severe alopecia areata than conventional treatments.

A man with vitiligo and alopecia saw quick skin and hair improvement with ruxolitinib, but skin color gains were lost after stopping treatment.

A medicine called tofacitinib worked to treat a hair loss condition linked with a muscle and skin disease.

Chemotherapy in the first trimester of pregnancy is risky, but in the second and third trimesters, it's generally safe with careful drug selection and timing.

Anticancer drugs are increasingly found in surface waters, and their long-term environmental effects are not well understood, requiring better testing methods.

Teriflunomide helps reduce multiple sclerosis symptoms and is safe for most patients.

Lupus affects the body and skin, causing joint pain and skin issues that can be treated with steroids and antimalarial drugs.

No effective treatment for frontal fibrosing alopecia was found, but oral 5-alpha-reductase inhibitors had the best response; for lichen planopilaris, topical corticosteroids were commonly used but had a high relapse rate.

Cancer therapy can cause various skin problems, including hair loss, skin darkening, painful hand-foot syndrome, and severe skin damage.

Fibromyalgia slightly more common in SLE patients but doesn't affect SLE activity assessments.

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

Voriconazole can cause serious side effects, especially in long-term use.

Treatments for permanent hair loss from scarring aim to stop further loss, not regrow hair, and vary by condition, with partial success common.

Pregnancy can increase lupus activity, but careful planning and treatment can improve outcomes.

Pegvaliase is recommended for treating adults with phenylketonuria.

Some common medications can harm male fertility, but many effects can be reversed.